Back
Royal Caribbean Group Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
66
RCL
Royal Caribbean Group
Last Price:
135.70
Seasonality Move:
2.11%
Buy
52
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
38.33
Seasonality Move:
-15.12%
Buy
66
Royal Caribbean Group (RCL)
is a Buy
Is Royal Caribbean Group a Buy, Sell or Hold?
- The current Royal Caribbean Group [RCL] share price is $139.63. The Score for RCL is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- RCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.03. The Score for CRBP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCL Stock Price Chart
What is Royal Caribbean Group's stock price today?
-
The Royal Caribbean Group share price today is $139.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCL is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.03
The current trend is relatively stagnant and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.18 | Buy |
| Relative Strength Index (14 RSI): | 59.93 | Buy |
| Chaikin Money Flow: | -2590114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.02 - 139.74) | Buy |
| Bollinger Bands (100): | (119.99 - 133.55) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 49.95 | Sell |
| Chaikin Money Flow: | 138813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.78 - 40.1) | Sell |
| Bollinger Bands (100): | (10.05 - 38.69) | Buy |
RCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.96 | Buy |
| 20-day SMA: | 133.92 | Buy |
| 50-day SMA: | 130.76 | Buy |
| 200-day SMA: | 111.97 | Buy |
| 8-day EMA: | 137.63 | Buy |
| 20-day EMA: | 134.91 | Buy |
| 50-day EMA: | 131.16 | Buy |
| 200-day EMA: | 113.3 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 38.11 | Sell |
| 50-day SMA: | 36.79 | Buy |
| 200-day SMA: | 15.23 | Buy |
| 8-day EMA: | 36.34 | Buy |
| 20-day EMA: | 37.22 | Sell |
| 50-day EMA: | 34.42 | Buy |
| 200-day EMA: | 20.11 | Buy |
Royal Caribbean Group Earnings Growth & RCL Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.31 per share, a decrease next quarter of $1.55 per share, an increase this year of $4.21 per share, and an increase next year of $1.68 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Royal Caribbean Group Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||